Ajovy is a medicine used to prevent migraine in adults who have migraines at least 4 days a month. The active substance contained in Ajovy is fremanezumab.
Therapeutic Indication
### Therapeutic indication Ajovy is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
Therapeutic Area (MeSH)
ATC Code
N02CD03
ATC Item
fremanezumab
Pharmacotherapeutic Group
Calcitonin gene-related peptide (CGRP) antagonists
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| fremanezumab | N/A | Fremanezumab |
EMA Name
Ajovy
Medicine Name
Ajovy
Aliases
N/ANo risk management plan link.
